Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

Conditions:   HNSCC;   Head and Neck Neoplasms
Interventions:   Drug: BYL719;   Drug: Poziotinib;   Drug: Nintedanib;   Drug: Abemaciclib;   Drug: Durvalumab,Tremelimumab
Sponsors:   Seoul National University Hospital;   Korean Cancer Study Group;   Chungnam National University Hospital
Recruiting - verified September 2017

http://ift.tt/2fLM0J2